Yang Yuanyuan, Guo Qiongya, Lu Min, Huang Yansheng, Yang Yu, Gao Chuanyu
Department of Cardiology, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Front Genet. 2023 Jan 11;13:1094332. doi: 10.3389/fgene.2022.1094332. eCollection 2022.
Myocardial infarction is a very dangerous cardiovascular disease with a high mortality rate under the modern developed medical technology. miRNA is a small molecule regulatory RNA discovered in recent years, which can play an important role in many cancers and other diseases. Medical data, machine learning and medical care strategies supporting the Internet of Things (IoMT) have certain applications in the treatment of myocardial infarction. However, the specific pathogenesis of myocardial infarction is still unclear. Therefore, this paper aimed to explore the expression of microRNA-320 and microRNA-204 in myocardial infarction and used the expression of microRNA-320 and microRNA-204 to predict the prognosis of patients with myocardial infarction. In order to discuss the expression of microRNA-320 and microRNA-204 in myocardial infarction in more detail. In this paper, 40 patients in the trial period were selected for clinical research, and 10 patients with normal cardiac function were selected in NHF group as control group. 10 patients with heart failure were selected as AMHF group. 10 patients with acute myocardial infarction were selected as AMNHF group. 10 patients with heart failure after old myocardial infarction were selected as OMHF group. AMHF group, AMNHF group and OMHF group were taken as the case group. This paper analyzed the difference of miR between different groups and determined that there were significant differences in the expression of miR-320 and miR-204 between different groups. Finally, the expression and prognosis of miR-320 and miR-204 in myocardial infarction were analyzed. The analysis results showed that the expression of microRNA-320 and microRNA-204 can inhibit the activity of myocardial cells. On the fifth day, the corresponding expression of microRNA-320 and microRNA-204 reduced the optical density of myocardial cells to 1.75 and 1.76, which was significantly lower than that on the first day. Moreover, excessive miR-320 expression and excessive miR-204 expression can increase the apoptosis rate of myocardial cells. The above results indicated that the high expression of microRNA-320 and microRNA-204 can be a bad prognostic factor in patients with myocardial infarction, showing that medical data, machine learning and medical care strategies supporting IoMT can play a role in the treatment of myocardial infarction. Therefore, it is urgent to understand the pathogenesis of heart failure after myocardial infarction and find new treatment schemes to improve the positive prognosis.
在现代发达的医疗技术条件下,心肌梗死是一种死亡率很高的非常危险的心血管疾病。微小RNA(miRNA)是近年来发现的一种小分子调节RNA,它在许多癌症和其他疾病中可发挥重要作用。支持物联网(IoMT)的医学数据、机器学习和医疗保健策略在心肌梗死的治疗中有一定应用。然而,心肌梗死的具体发病机制仍不清楚。因此,本文旨在探讨微小RNA - 320和微小RNA - 204在心肌梗死中的表达情况,并利用微小RNA - 320和微小RNA - 204的表达来预测心肌梗死患者的预后。为了更详细地讨论微小RNA - 320和微小RNA - 204在心肌梗死中的表达。本文选取40例试验期患者进行临床研究,选取10例心功能正常患者作为NHF组作为对照组。选取10例心力衰竭患者作为AMHF组。选取10例急性心肌梗死患者作为AMNHF组。选取10例陈旧性心肌梗死后心力衰竭患者作为OMHF组。将AMHF组、AMNHF组和OMHF组作为病例组。本文分析了不同组之间miR的差异,确定不同组之间miR - 320和miR - 204的表达存在显著差异。最后,分析了miR - 320和miR - 204在心肌梗死中的表达及预后情况。分析结果表明,微小RNA - 320和微小RNA - 204的表达可抑制心肌细胞的活性。在第5天,微小RNA - 320和微小RNA - 204的相应表达使心肌细胞的光密度降低至1.75和1.76,显著低于第1天。此外,miR - 320表达过高和miR - 204表达过高可增加心肌细胞的凋亡率。上述结果表明,微小RNA - 320和微小RNA - 204的高表达可能是心肌梗死患者不良的预后因素,表明支持IoMT的医学数据、机器学习和医疗保健策略在心肌梗死治疗中可发挥作用。因此,迫切需要了解心肌梗死后心力衰竭的发病机制并寻找新的治疗方案以改善预后。